Skip to main content

Semax vs Dihexa

Both Semax and Dihexa are used for cognitive and neuroprotection. Here's how their evidence, dosing, and regulatory status actually compare.

Semax

Evidence B

Semax (MEHFPGP)

A synthetic ACTH fragment that increases BDNF levels and enhances focus, memory, and mental clarity. Delivered intranasally for rapid cognitive effects.

View full Semax profile →

Dihexa

Evidence C

Dihexa (PNB-0408)

An angiotensin IV-derived hexapeptide that mimics hepatocyte growth factor (HGF)/c-Met signaling and produced rapid synaptogenesis in animal models. No human trials.

View full Dihexa profile →

Side-by-Side

AttributeSemaxDihexa
Evidence GradeBC
FDA StatusNot FDA-approved in US — approved in Russia for stroke and cognitive disordersNot FDA-approved — research compound (HGF/c-Met-mimetic)
Typical Dose200–600 mcg intranasal, morning8–45 mg orally daily (research-only)
Clinics Indexed8910
Categoriescognitive, neuroprotectioncognitive, neuroprotection

Key reported benefits — Semax

  • BDNF increase
  • Enhanced focus
  • Memory improvement
  • Neuroprotection

Key reported benefits — Dihexa

  • Synaptogenesis (preclinical)
  • Memory improvement (animal)
  • Possible Alzheimer's relevance

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons